• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC THERMOCOOL® SMART TOUCH® SF BI-DIRECTIONAL NAVIGATION CATHETER; CARDIAC ABLATION PERCUTANEOUS CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC THERMOCOOL® SMART TOUCH® SF BI-DIRECTIONAL NAVIGATION CATHETER; CARDIAC ABLATION PERCUTANEOUS CATHETER Back to Search Results
Catalog Number SEE SECTION 10
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pulmonary Edema (2020); Heart Block (4444)
Event Date 06/01/2017
Event Type  Death  
Manufacturer Narrative
B2.Date of death - the exact date of death is unknown at this time and so this field was populated with 28-sep-2023 which is the date of the drra report submission.Section d4: the catalog for this is unk_smart touch bidirectional sf.Since no device has been received for analysis, no product investigation can be performed, and the customer complaint cannot be confirmed.Device history record (dhr) review cannot be conducted because no lot number was provided by the customer.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Biosense webster manufacturer's reference number (b)(4) has five reports: (1) mdr # for id (b)(6) experienced complete heart block (heart block av) and (pulmonary edema) within 7 days of index ablation procedure.This patient also died within 88 days of the safety evaluation period but the cause of death information is not available.(2) mfr # 2029046-2023-02441 for id (b)(6) experienced cardiac tamponade/perforation (cardiac tamponade) requiring pericardiocentesis (recognized procedural complication) within 30 days of index ablation procedure.(3) mfr # 2029046-2023-02442 for id (b)(6) experienced cardiac tamponade/perforation (cardiac tamponade) requiring pericardiocentesis (recognized procedural complication) within 30 days of index ablation procedure.(4) mfr # 2029046-2023-02443 for id (b)(6) experienced cardiac tamponade/perforation (cardiac tamponade) requiring pericardiocentesis (recognized procedural complication) within 30 days of index ablation procedure.(5) mfr # 2029046-2023-02444 for id (b)(6) experienced atrio-ventricular block, second degree (heart block) and acute pulmonary edema (pulmonary edema) within 7 days of index ablation procedure.
 
Event Description
A database related research activity (drra) was received regarding the study: ''real-world experience of persistent atrial fibrillation catheter.Ablation with thermocool smarttouch sf catheter.36-month interim report (pas progress report)''.Table 8 of report lists adverse events per patient that occurred within safety evaluation period.Adverse events and interventions possibly associated with use of an unidentified thermocool smarttouch® sf catheters: qty 1 - id (b)(6) experienced atrio-ventricular block, second degree (heart block) and acute pulmonary edema (pulmonary edema) within 7 days of index ablation procedure.Qty 1 - id (b)(6) experienced cardiac tamponade/perforation (cardiac tamponade) requiring pericardiocentesis (recognized procedural complication) within 30 days of index ablation procedure.Qty 1 - id (b)(6) experienced cardiac tamponade/perforation (cardiac tamponade) requiring pericardiocentesis (recognized procedural complication) within 30 days of index ablation procedure.Qty 1 - id (b)(6) experienced cardiac tamponade/perforation (cardiac tamponade) requiring pericardiocentesis (recognized procedural complication) within 30 days of index ablation procedure.Qty 1 - id (b)(6) experienced complete heart block (heart block av) and (pulmonary edema) within 7 days of index ablation procedure.This patient also died within 88 days of the safety evaluation period but the cause of death information is not available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERMOCOOL® SMART TOUCH® SF BI-DIRECTIONAL NAVIGATION CATHETER
Type of Device
CARDIAC ABLATION PERCUTANEOUS CATHETER
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
3035526892
MDR Report Key18013238
MDR Text Key326632881
Report Number2029046-2023-02440
Device Sequence Number1
Product Code LPB
UDI-Device Identifier10846835010145
UDI-Public10846835010145
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional
Reporter Occupation Other
Type of Report Initial
Report Date 10/26/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/26/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberSEE SECTION 10
Was Device Available for Evaluation? No
Date Manufacturer Received09/28/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Life Threatening;
-
-